Cargando…
Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes
INTRODUCTION: COVID-19 cases are on surge; however, there is no efficient treatment or vaccine that can be used for its management. Numerous clinical trials are being reviewed for use of different drugs, biologics, and vaccines in COVID-19. A much empirical approach will be to repurpose existing dru...
Autores principales: | Kaur, Harpinder, Shekhar, Nishant, Sharma, Saurabh, Sarma, Phulen, Prakash, Ajay, Medhi, Bikash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778723/ https://www.ncbi.nlm.nih.gov/pubmed/33389725 http://dx.doi.org/10.1007/s43440-020-00195-y |
Ejemplares similares
-
In silico docking and comparative ADMET profile of different glycogen synthase kinase 3 beta inhibitors as the potential leads for the development of anti-Alzheimer drug therapy
por: Prajapat, Manisha, et al.
Publicado: (2020) -
Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2
por: Prajapat, Manisha, et al.
Publicado: (2020) -
In Silico Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics and Binding Free Energy Calculations
por: Shekhar, Nishant, et al.
Publicado: (2020) -
COVID-19 pandemic: A review based on current evidence
por: Mahalmani, Vidya M., et al.
Publicado: (2020) -
Three-dimensional drugs: A new era in the pharmaceutical development
por: Kumar, Harish, et al.
Publicado: (2017)